SCOPUS 정보 검색 플랫폼

Annals of Plastic Surgery

Volumn 68, Issue 2, 2012, Pages 226-228

Novel strategies for managing infantile hemangiomas: A review

(2) Azzopardi, Silvan a Wright, Thomas Christian a

a MORRISTON HOSPITAL (United Kingdom)

Author keywords

bleomycin; Hemangioma; propranolol; steroids; treatment; vincristine

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BLEOMYCIN; IMMUNOLOGIC FACTOR; PREGNANE DERIVATIVE; PROPRANOLOL; VINCRISTINE;

HEMANGIOMA; HUMAN; INFANT; REVIEW;

ADRENERGIC BETA-ANTAGONISTS; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BLEOMYCIN; HEMANGIOMA; HUMANS; IMMUNOLOGIC FACTORS; INFANT; INTERFERON-ALPHA; PREGNADIENES; PROPRANOLOL; VINCRISTINE;

EID: 84856614133 PISSN: 01487043 EISSN: None Source Type: Journal
DOI: 10.1097/SAP.0b013e318216b4f8 Document Type: Review

Times cited : (11)

References (23)

1
- 0034242859
- Vascular anomalies
- Mulliken JB. Vascular anomalies. Curr Probl Surg. 2000;37:517-558.
- (2000) Curr Probl Surg. , vol.37 , pp. 517-558
- Mulliken, J.B.¹

2
- 1642353393
- Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations
- DOI 10.1007/s00383-003-1058-6
- Muir T, Kirsten M, Fourie P, et al. Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations. Pediatr Surg Int. 2004;19:766-773. (Pubitemid 38387457)
- (2004) Pediatric Surgery International , vol.19 , Issue.12 , pp. 766-773
- Muir, T.¹ Kirsten, M.² Fourie, P.³ Dippenaar, N.⁴ Ionescu, G.O.⁵

3
- 67649135165
- Endangering cutaneous infantile hemangioma treated with vincristine: A case report
- Wharton S, Soueid A, Nishikawa H, et al. Endangering cutaneous infantile hemangioma treated with vincristine: a case report. Eur J Plast Surg. 2009;32:157-161.
- (2009) Eur J Plast Surg. , vol.32 , pp. 157-161
- Wharton, S.¹ Soueid, A.² Nishikawa, H.³

4
- 33644850855
- Intralesional bleomycin for the treatment ofhemangiomas
- Pienaar C, Graham R, Geldenhuys S, et al. Intralesional bleomycin for the treatment ofhemangiomas. Plast Reconstr Surg. 2006;117:221-226.
- (2006) Plast Reconstr Surg. , vol.117 , pp. 221-226
- Pienaar, C.¹ Graham, R.² Geldenhuys, S.³

5
- 79951677473
- Low-dose propranolol for infantile haemangioma
- doi:10.1016/j.bjps.2010.06.010
- Tan ST, Itinteang T, Leadbitter P. Low-dose propranolol for infantile haemangioma. JPlast Reconstr Aesthet Surg. 2010;doi:10.1016/j.bjps.2010.06.010.
- (2010) JPlast Reconstr Aesthet Surg.
- Tan, S.T.¹ Itinteang, T.² Leadbitter, P.³

6
- 0014037643
- Induced resolution of cavernous hemangiomas following prednisolone therapy
- Zarem HA, Edgerton MT. Induced resolution of cavernous hemangiomas following prednisolone therapy. Plast Reconstr Surg. 1967;39:76-83.
- (1967) Plast Reconstr Surg. , vol.39 , pp. 76-83
- Zarem, H.A.¹ Edgerton, M.T.²

7
- 0032730533
- Complications of systemic corticosteroid therapy for problematic hemangioma
- DOI 10.1097/00006534-199911000-00002
- Boon LM, Mac Donald DM, Mulliken JB. Complications of systemic corti-costeroid therapy for problematic hemangioma. Plast Reconstr Surg. 1999; 104:1616-1623. (Pubitemid 29510480)
- (1999) Plastic and Reconstructive Surgery , vol.104 , Issue.6 , pp. 1616-1623
- Boon, L.M.¹ MacDonald, D.M.² Mulliken, J.B.³

8
- 0031917719
- Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy
- DOI 10.1016/S0022-3476(98)70034-4
- Barlow CF, Priebe CJ, Mulliken JB, et al. Spastic diplegia as a complication of Interferon alfa-2a treatment of hemangiomas of infancy. J Pediatrics. 1998;132:527-530. (Pubitemid 28180264)
- (1998) Journal of Pediatrics , vol.132 , Issue.3 , pp. 527-530
- Barlow, C.F.¹ Priebe, C.J.² Mulliken, J.B.³ Barnes, P.D.⁴ MacDonald, D.⁵ Folkman, J.⁶ Ezekowitz, R.A.B.⁷

9
- 1242285522
- Vincristine as a treatment for a large haemangioma threatening vital functions
- DOI 10.1016/j.bjps.2003.11.003
- Fawcett SL, Grant I, Hall PN, et al. Vincristine as a treatment for a large haemangioma threatening vital functions. BJPS. 2004;57:168-171. (Pubitemid 38239893)
- (2004) British Journal of Plastic Surgery , vol.57 , Issue.2 , pp. 168-171
- Fawcett, S.L.¹ Grant, I.² Hall, P.N.³ Kelsall, A.W.R.⁴ Nicholson, J.C.⁵

10
- 80052703463
- How to use bleomycin A5 for infantile maxillofacial haemangiomas: Clinical evaluation of 82 consecutive cases
- doi:10.1016/j.jcms.2010.06.002
- Luo Q, Zhao F. How to use bleomycin A5 for infantile maxillofacial haemangiomas: clinical evaluation of 82 consecutive cases. J Craniomaxil-lofac Surg. 2010;doi:10.1016/j.jcms.2010.06.002.
- (2010) J Craniomaxil-lofac Surg.
- Luo, Q.¹ Zhao, F.²

11
- 0015151890
- Clinical study with bleomycin
- Shastri S, Slayton RE, Wolter J, et al. Clinical study with bleomycin. Cancer. 1971;28:1142-1146
- (1971) Cancer. , vol.28 , pp. 1142-1146
- Shastri, S.¹ Slayton, R.E.² Wolter, J.³

12
- 0030837343
- Efficacy of bleomycin treatment for symptomatic heman-giomas in children
- Kullendorff CM. Efficacy of bleomycin treatment for symptomatic heman-giomas in children. Pediatr Surg Int. 1997;12:526.
- (1997) Pediatr Surg Int. , vol.12 , pp. 526
- Kullendorff, C.M.¹

13
- 0017726981
- Bleomycin treatment for cystic hygroma in children
- Yura J. Bleomycin treatment for cystic hygroma in children. Arch Jap Chir. 5 1977;46:607-614. (Pubitemid 8229832)
- (1977) Archiv fur Japanische Chirurgie , vol.46 , Issue.5 , pp. 607-614
- Yura, J.¹ Hashimoto, T.² Tsuruga, N.³ Shibata, K.⁴

14
- 20844457286
- Role of intralesional bleomycin in the treatment of complicated hemangiomas: Prospective clinical study
- Omidvari S, Nezakatgoo N, Ahmadloo N, et al. Role ofintralesional bleo-mycin in the treatment of complicated hemangiomas: prospective clinical study. Dermatol Surg. 2005;31:499-501. (Pubitemid 43073183)
- (2005) Dermatologic Surgery , vol.31 , Issue.5 , pp. 499-501
- Omidvari, S.¹ Nezakatgoo, N.² Ahmadloo, N.³ Mohammadianpanah, M.⁴ Mosalaei, A.⁵

15
- 84912943550
- Clinical trial of bleomycin in solid tumors and lymphomas
- Luce JK. Clinical trial of bleomycin in solid tumors and lymphomas. Proc Am Assoc Cancer Res. 1969;10:38.
- (1969) Proc Am Assoc Cancer Res. , vol.10 , pp. 38
- Luce, J.K.¹

16
- 0030795407
- A new treatment with bleomycin for complicated cutaneous hemangioma in children
- Sarihan H, Mocan H, Yildiz K,etal. A new treatment with bleomycin for compli-cated cutaneous hemangioma in children Eur JPediatr Surg. 1997;7:158-162. (Pubitemid 27340021)
- (1997) European Journal of Pediatric Surgery , vol.7 , Issue.3 , pp. 158-162
- Sarihan, H.¹ Mocan, H.² Yildiz, K.³ Abes, M.⁴ Akyazici, R.⁵

17
- 0015609611
- A clinical review of Bleomycin - A new antineoplastic agent
- Blum R. A clinical review of Bleomycin-a new antineoplastic agent Cancer. 1973;31:903-914.
- (1973) Cancer. , vol.31 , pp. 903-914
- Blum, R.¹

18
- 45149115634
- Propranolol for severe hemangiomas ofinfancy
- Leaute-Labreze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas ofinfancy. NEngl JMed. 2008;358:2649-2651.
- (2008) NEngl JMed. , vol.358 , pp. 2649-2651
- Leaute-Labreze, C.¹ Dumas De La Roque, E.² Hubiche, T.³

19
- 70349252008
- Propranolol for severe infantile hemangiomas: Follow-up report
- Sans V, de la Roque ED, Berge J, et al. Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics. 2009;124:423-431.
- (2009) Pediatrics. , vol.124 , pp. 423-431
- Sans, V.¹ De La Roque, E.D.² Berge, J.³

20
- 0030664140
- CAMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activation
- DOI 10.1002/(SICI)1097-4644(19971201)67:3<353::AID-JCB7>3.0.CO;2-V
- D'Angelo G, Lee H, Weiner RI. c AMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activation. J Cell Biochem. 1997;67:353-366. (Pubitemid 27509471)
- (1997) Journal of Cellular Biochemistry , vol.67 , Issue.3 , pp. 353-366
- D'Angelo, G.¹ Lee, H.² Weiner, R.I.³

21
- 77954867089
- Proranolol for infantile haemangiomas: Insights into the molecular mechanisms ofaction
- Storch CH, Hoeger PH. Proranolol for infantile haemangiomas: insights into the molecular mechanisms ofaction. Br J Dermatol. 2010;163:269-274.
- (2010) Br J Dermatol. , vol.163 , pp. 269-274
- Storch, C.H.¹ Hoeger, P.H.²

22
- 74349101442
- Propranolol for complicated infantile haemangiomas: A case series of 30 infants
- Manunza F, Syed S, Laguda B, et al. Propranolol for complicated infantile haemangiomas: a case series of 30 infants. Br J Dermatol. 2010;162:466-468.
- (2010) Br J Dermatol. , vol.162 , pp. 466-468
- Manunza, F.¹ Syed, S.² Laguda, B.³

23
- 58149094583
- More on propranolol for hemangiomas ofinfancy
- Siegfried EC, Keenan WJ, Al-Jureidini S, et al. More on propranolol for hemangiomas ofinfancy. NEngl JMed. 2008;359:2846-2847.
- (2008) NEngl JMed. , vol.359 , pp. 2846-2847
- Siegfried, E.C.¹ Keenan, W.J.² Al-Jureidini, S.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.